News Website

Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - News-Press NOW

Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) News-Press NOW

Published: April 23, 2026, 12:56 p.m.

Read Full Article

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise - Newswise

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise Newswise

Published: April 21, 2026, 1:10 a.m.

Read Full Article

Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing - Contemporary OB/GYN

Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing Contemporary OB/GYN

Published: April 20, 2026, 4:29 p.m.

Read Full Article

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments - Roswell Park Comprehensive Cancer Center

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments Roswell Park Comprehensive Cancer Center

Published: April 20, 2026, 1 p.m.

Read Full Article

Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test - SelectScience

Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test SelectScience

Published: April 20, 2026, 8:49 a.m.

Read Full Article

High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN

Published: April 20, 2026, 8:14 a.m.

Read Full Article

BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily

BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily

Published: April 18, 2026, 6:23 p.m.

Read Full Article

Lena Dunham and the art monster - New Statesman

Lena Dunham and the art monster New Statesman

Published: April 18, 2026, 1:36 a.m.

Read Full Article

Famesick review: Lena Dunham, art monster - New Statesman

Famesick review: Lena Dunham, art monster New Statesman

Published: April 18, 2026, 1:30 a.m.

Read Full Article

ACOG updates guidance for evaluating postmenopausal bleeding - Contemporary OB/GYN

ACOG updates guidance for evaluating postmenopausal bleeding Contemporary OB/GYN

Published: April 17, 2026, 7:46 p.m.

Read Full Article

Latest Articles

Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - News-Press NOW

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments | Newswise - Newswise

Mariam Naqvi, MD, on eliminating bias in hospital toxicology testing - Contemporary OB/GYN

JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments - Roswell Park Comprehensive Cancer Center

Feinstein Institutes' ROSE study continues to advance critical endometriosis diagnostic test - SelectScience

High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily

Lena Dunham and the art monster - New Statesman

Famesick review: Lena Dunham, art monster - New Statesman

ACOG updates guidance for evaluating postmenopausal bleeding - Contemporary OB/GYN

Subscribe to Our Newsletter